ArticlePaediatric drugs2022

Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr).

Jinane Zitouni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.